Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension of oral temsirolimus in relapsing multiple sclerosis
2005-000171-18Phase 2Completed
- Sponsor
- Wyeth
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in multiple sclerosis (MS) and secondary-progressive multiple sclerosis (SPMS), sponsored by Wyeth. Primary endpoint: Safety. Started Apr 2005; status: completed.
02
Drugs
temsirolimus
03
Conditions
multiple sclerosis (MS)secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on 2005-000171-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000171-18.